B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells

ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.25912/RDF_1660607767379&rft.title=B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells&rft.identifier=10.25912/RDF_1660607767379&rft.publisher=Queensland University of Technology&rft.description=Fenbendazole, which is an anthelmintic, was encapsulated into succinylated beta-lactoglobulin-modified, amine-functionalised mesoporous silica nanoparticles to protect the drug throughout gastrointestinal tract and improve its anticancer effects against prostate cancer. The data resulting from this study include the Higuchi kinetic model of the drug release and the toxicity effects of the prepared formulations against HEK-293 cells. &rft.creator=Koohi Moftakhari Esfahani, Maedeh &rft.creator=Alavi, Seyedebrahim &rft.creator=J. Cabot, Peter &rft.creator=Islam, Nazrul &rft.creator=L. Izake, Emad &rft.date=2022&rft.edition=1&rft.relation=https://eprints.qut.edu.au/229955/&rft.coverage=153.317870,-26.996845 152.668523,-26.996845 152.668523,-27.767441 153.317870,-27.767441 153.317870,-26.996845&rft_rights=© Maedeh Koohi Moftakhari Esfahani, 2022.&rft_rights=Creative Commons Attribution 3.0 http://creativecommons.org/licenses/by/4.0/&rft_subject=Nanotechnology&rft_subject=ENGINEERING&rft_subject=Biotechnology&rft_subject=Biomaterials&rft_subject=Biomedical engineering&rft.type=dataset&rft.language=English Access the data